查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2041751

DNA微陣列市場預測至2034年—按類型、技術、應用、最終用戶和地區分類的全球分析

DNA Microarray Market Forecasts to 2034 - Global Analysis By Type (Oligonucleotide DNA Microarrays (oDNA), Complementary DNA Microarrays (cDNA) and Other Types), Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 預測，全球 DNA 微陣列市場預計將在 2026 年達到 50 億美元，並在預測期內以 10.7% 的複合年成長率成長，到 2034 年達到 113 億美元。

DNA微陣列是分子生物學中一種強大的工具，可用於在單次實驗中同時分析數千個基因的表現量。它由一系列包含DNA探針的微小點組成，每個探針代表一個特定的基因或片段。透過將螢光標記的DNA或RNA樣本與這些探針雜交，科學家可以檢測和測量給定樣本中數千個基因的表達水平，從而深入了解生物系統中基因的功能、調控和相互作用。這項技術在基因組學、遺傳學和生物醫學研究等領域中發揮著至關重要的作用。

根據加拿大癌症協會的估計，該國報告了 233,900 例新增癌症病例，造成 85,100 人死亡。

基因組研究進展

DNA微陣列市場的基因組學研究取得了顯著進展，徹底改變了個人化醫療和疾病認知。微陣列技術的創新正推動著基因表現、突變分析和基因組變異的研究。改進的生物資訊學工具正在簡化數據分析，並為複雜的生物系統提供全面的洞察。這些進步正在加速臨床診斷、藥物研發和生物標記識別等領域的應用，為精準醫療和標靶治療鋪路。

倫理和隱私問題

DNA微陣列技術引發了倫理方面的擔憂，因為基因數據可能被濫用，導致隱私侵犯、知情同意和歧視等問題。收集到的大量資料可能被濫用，在未獲得充分知情同意的情況下，可能洩露敏感的個人資訊。此外，人們對結果的準確性和解讀也存在擔憂，不確定或誤讀的基因數據可能會對個人生活產生影響。這些因素阻礙了該領域的發展。

對個人化醫療的需求日益成長

人們對個人化醫療日益成長的興趣正在推動市場需求的激增。這一趨勢得益於能夠快速、準確地分析個別基因組成的技術，這些技術能夠制定個人化的治療方案。隨著醫學向精準醫療轉型，這些微陣列在提供基因變異資訊、支持標靶治療和改善患者預後方面發揮著至關重要的作用。這種需求的成長凸顯了它們在推動個人化醫療解決方案方面的關鍵作用。

高成本

由於需要複雜的製造流程、專用設備和嚴格的品管措施，該市場歷來面臨高成本。這些因素導致原料、研發和生產成本飆升。此外，技術的複雜性以及對精度和可靠性的要求進一步推高了成本，使得微陣列成為用於研究和診斷的高價值投資。

新冠疫情的影響：

新冠疫情為DNA微陣列市場帶來了波動。初期，由於供應鏈中斷和實驗室關閉，市場成長放緩。然而，診斷和研究需求的成長，以及個人化醫療的進步，推動了市場成長。遠距辦公和數據分析技術的快速創新和應用也對市場產生了積極影響。總體而言，儘管疫情造成了波動，但最終加速了技術進步和市場在各個應用領域的擴張。

在預測期內，藥物基因體學領域預計將是最大的領域。

在預測期內，藥物基因體學領域預計將成為規模最大的領域。此領域利用DNA微陣列技術來辨識影響藥物代謝、療效和副作用的基因變異，從而指導個人化治療方案的發展。精準醫療的需求推動了藥物基因體學的發展，精準醫療能夠實現個人化的藥物選擇和劑量調整，進而改善患者的治療效果。藥物基因組學在醫療產業追求個人化治療的過程中發揮著至關重要的作用。

在預測期內，診斷中心細分市場預計將呈現最高的複合年成長率。

預計在預測期內，診斷中心細分市場將呈現最高的複合年成長率。這些中心利用微陣列技術同時分析大量基因，辨識與疾病相關的突變。微陣列平台的進步提高了準確性和處理能力，從而加快了診斷速度，並推動了個人化治療策略的發展。該細分市場之所以成長，是因為它在解碼基因訊息方面發揮關鍵作用，並推動著標靶治療和精準醫療干預的創新。

市佔率最大的地區：

預計北美將在預測期內佔據最大的市場佔有率。該地區的市場成長主要得益於基因組學、個人化醫療和生物技術領域投資的不斷增加。先進醫療技術的日益普及、策略聯盟的建立以及有利的法規環境等因素，都促進了市場擴張，滿足了研究、診斷和製藥等多個應用領域的需求。

複合年成長率最高的地區：

預計亞太地區在預測期內將維持最高的複合年成長率。該地區市場成長的主要驅動力是不斷成長的個人化醫療、基因研究和診斷需求。主要參與者、策略聯盟以及政府對基因組研究的支持，都促進了市場的穩定成長。此外，醫療專業人員和研究人員對基因組技術的認知度和應用率不斷提高，也進一步推動了該地區市場的發展。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

第2章：引言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進因素
  • 抑制因子
  • 機會
  • 威脅
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭

第5章 全球DNA微陣列市場：依類型分類

  • 寡核苷酸DNA微陣列（oDNA）
  • 互補DNA微陣列（cDNA）
  • 其他類型

第6章 全球DNA微陣列市場：依技術分類

  • 噴墨
  • 微流體技術
  • 雜合反應
  • 其他技術

第7章 全球DNA微陣列市場：依應用分類

  • 藥物基因體學
  • 基因表現分析
  • 癌症調查
  • 基因型鑒定
  • 蛋白質體學
  • 毒理基因組學
  • 遺傳學
  • 藥物發現
  • 法醫學
  • 神經科學
  • 其他用途

第8章 全球DNA微陣列市場：依最終用戶分類

  • 受託研究機構（CRO）
  • 生技公司
  • 醫院和診所
  • 學術研究機構
  • 診斷中心
  • 其他最終用戶

第9章 全球DNA微陣列市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太國家
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 其他中東和非洲國家

第10章 主要發展

  • 合約、夥伴關係、合作關係、合資企業
  • 收購與併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第11章：公司簡介

  • Applied Micro Arrays
  • Illumina, Inc.
  • QIAGEN
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • PerkinElmer, Inc.
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories
  • PerkinElmer
  • Oxford Gene Technology（OGT）
  • Arrayit Corporation
  • Roche NimbleGen
  • Savyon Diagnostics
  • WaferGen Biosystems
  • Novacyt Group
  • Enzo Biochem, Inc.
Product Code: SMRC24814

According to Stratistics MRC, the Global DNA Microarray Market is accounted for $5.0 billion in 2026 and is expected to reach $11.3 billion by 2034 growing at a CAGR of 10.7% during the forecast period. A DNA microarray is a powerful tool used in molecular biology to simultaneously analyze the expression levels of thousands of genes in a single experiment. It consists of an arrayed series of microscopic spots containing DNA probes, each spot representing a specific gene or fragment of a gene. By hybridizing fluorescently labelled DNA or RNA samples onto these spots, scientists can detect and measure the expression levels of thousands of genes in a given sample, providing insights into gene function, regulation, and interactions within biological systems. This technology has been pivotal in fields like genomics, genetics, and biomedical research.

According to estimates by the Canadian Cancer Society, the country reported 233,900 new cancer cases with 85,100 deaths.

Market Dynamics:

Driver:

Advancements in genomics research

Genomics research within the DNA Microarray market has witnessed substantial advancements, revolutionizing personalized medicine and disease understanding. Innovations in microarray technology propel research in gene expression, mutation analysis, and genomic variations. Improved bioinformatics tools streamline data analysis, enabling comprehensive insights into complex biological systems. These advancements foster applications in clinical diagnostics, drug discovery, and biomarker identification, paving the way for precision medicine and targeted therapies.

Restraint:

Ethical and privacy concerns

DNA Microarrays pose ethical concerns due to potential misuse of genetic data, raising issues of privacy infringement, consent, and discrimination. The vast data collected can be exploited, compromising individuals' sensitive information without their informed consent. Additionally, concerns arise regarding the accuracy and interpretation of results, potentially impacting individuals' lives based on uncertain or misinterpreted genetic data. These are the factors restraining the growth of the segment.

Opportunity:

Rising demand for personalized medicine

The market is witnessing a surge in demand due to the growing interest in personalized medicine. This trend is fuelled by the technology's ability to analyze an individual's genetic makeup swiftly and accurately, enabling tailored treatment plans. As healthcare shifts toward precision medicine, these microarrays play a pivotal role by offering insights into genetic variations, aiding in targeted therapies, and enhancing patient outcomes. This rising demand underscores the pivotal role in advancing personalized healthcare solutions.

Threat:

High costs

The market has historically faced high costs due to intricate manufacturing processes, specialized equipment, and the need for precise quality control measures. These factors contribute to elevated expenses in raw materials, research, development, and production. Additionally, the complexity of the technology and the demand for accuracy and reliability further drives up costs, making microarrays a costly investment for research and diagnostic purposes.

Covid-19 Impact:

The COVID-19 pandemic triggered fluctuations in the DNA Microarray market. Initially, disruptions in supply chains and lab closures led to a slowdown. However, increased demand for diagnostics and research purposes, along with advancements in personalized medicine, boosted market growth. Rapid innovation and adaptation in technology for remote work and data analysis also influenced the market positively. Overall, the pandemic caused fluctuations but ultimately accelerated technological advancements and market expansion in applications.

The Pharmacogenomics segment is expected to be the largest during the forecast period

The pharmacogenomics segment is expected to be the largest during the forecast period. This segment utilizes DNA microarrays to identify genetic variations influencing drug metabolism, efficacy, and adverse reactions, guiding personalized treatment approaches. Its growth is driven by the demand for precision medicine, enabling tailored drug selection and dosing for better patient outcomes, making it a pivotal player in the healthcare industry's quest for personalized therapeutic interventions.

The diagnostic centers segment is expected to have the highest CAGR during the forecast period

The diagnostic centers segment is expected to have the highest CAGR during the forecast period. These centers employ microarrays to simultaneously examine numerous genes, identifying variations linked to illnesses. Advancements in microarray platforms enhance precision and throughput, fostering quicker diagnoses and personalized treatment strategies. This market segment thrives due to its pivotal role in decoding genetic information, driving innovation for targeted therapies and precise medical interventions.

Region with largest share:

North America is projected to hold the largest market share during the forecast period. The region's market growth is propelled by rising investments in genomics, personalized medicine, and biotechnology. Factors such as increased adoption of advanced healthcare technologies, strategic collaborations, and a supportive regulatory environment contribute to the market's expansion, catering to diverse applications across research, diagnostics, and pharmaceutical industries.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period. The region's market witnesses escalating demand for personalized medicine, genetic research, and diagnostics, fostering market expansion. Key players, strategic collaborations, and government support for genomics research contribute to the market's steady rise. Moreover, growing awareness and adoption of genomic technologies among healthcare professionals and researchers further fuel the market's evolution in the region.

Key players in the market

Some of the key players in DNA Microarray market include Applied Micro Arrays, Illumina, Inc., QIAGEN, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Merck KGaA, Agilent Technologies, Inc., Bio-Rad Laboratories, PerkinElmer, Oxford Gene Technology (OGT), Arrayit Corporation, Roche NimbleGen, Savyon Diagnostics, WaferGen Biosystems, Novacyt Group and Enzo Biochem, Inc.

Key Developments:

In August 2022, Thermo Fisher Scientific launched a new chromosomal microarray, the Applied Biosystem CytoScan HD Accel array, to improve cytogenetic research lab productivity, efficiency, and profitability with two-day turnaround time. This strategy helped the company to expand their product portfolio.

In May 2022, Qatar Genome Program and Thermo Fisher Scientific announced a partnership to accelerate genomic research and clinical applications of predictive genomics in Qatar.

Types Covered:

  • Oligonucleotide DNA Microarrays (oDNA)
  • Complementary DNA Microarrays (cDNA)
  • Other Types

Technologies Covered:

  • Inkjet
  • Microfluidics
  • Hybridization
  • Other Technologies

Applications Covered:

  • Gene Expression Analysis
  • Cancer Research
  • Genotyping
  • Genetics
  • Drug Discovery
  • Forensic Science
  • Neuroscience
  • Other Applications

End Users Covered:

  • Contract Research Organizations (CROs)
  • Biotechnology Companies
  • Hospitals and Clinics
  • Academic and Research Institutes
  • Diagnostic Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global DNA Microarray Market, By Type

  • 5.1 Introduction
  • 5.2 Oligonucleotide DNA Microarrays (oDNA)
  • 5.3 Complementary DNA Microarrays (cDNA)
  • 5.4 Other Types

6 Global DNA Microarray Market, By Technology

  • 6.1 Introduction
  • 6.2 Inkjet
  • 6.3 Microfluidics
  • 6.4 Hybridization
  • 6.5 Other Technologies

7 Global DNA Microarray Market, By Application

  • 7.1 Introduction
  • 7.2 Pharmacogenomics
  • 7.3 Gene Expression Analysis
  • 7.4 Cancer Research
  • 7.5 Genotyping
  • 7.6 Proteomics
  • 7.7 Toxicogenomics
  • 7.8 Genetics
  • 7.9 Drug Discovery
  • 7.10 Forensic Science
  • 7.11 Neuroscience
  • 7.12 Other Applications

8 Global DNA Microarray Market, By End User

  • 8.1 Introduction
  • 8.2 Contract Research Organizations (CROs)
  • 8.3 Biotechnology Companies
  • 8.4 Hospitals and Clinics
  • 8.5 Academic and Research Institutes
  • 8.6 Diagnostic Centers
  • 8.7 Other End Users

9 Global DNA Microarray Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Applied Micro Arrays
  • 11.2 Illumina, Inc.
  • 11.3 QIAGEN
  • 11.4 F. Hoffmann-La Roche Ltd.
  • 11.5 Thermo Fisher Scientific, Inc.
  • 11.6 PerkinElmer, Inc.
  • 11.7 Merck KGaA
  • 11.8 Agilent Technologies, Inc.
  • 11.9 Bio-Rad Laboratories
  • 11.10 PerkinElmer
  • 11.11 Oxford Gene Technology (OGT)
  • 11.12 Arrayit Corporation
  • 11.11 Roche NimbleGen
  • 11.14 Savyon Diagnostics
  • 11.15 WaferGen Biosystems
  • 11.16 Novacyt Group
  • 11.17 Enzo Biochem, Inc.

List of Tables

  • Table 1 Global DNA Microarray Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global DNA Microarray Market Outlook, By Type (2023-2034) ($MN)
  • Table 3 Global DNA Microarray Market Outlook, By Oligonucleotide DNA Microarrays (oDNA) (2023-2034) ($MN)
  • Table 4 Global DNA Microarray Market Outlook, By Complementary DNA Microarrays (cDNA) (2023-2034) ($MN)
  • Table 5 Global DNA Microarray Market Outlook, By Other Types (2023-2034) ($MN)
  • Table 6 Global DNA Microarray Market Outlook, By Technology (2023-2034) ($MN)
  • Table 7 Global DNA Microarray Market Outlook, By Inkjet (2023-2034) ($MN)
  • Table 8 Global DNA Microarray Market Outlook, By Microfluidics (2023-2034) ($MN)
  • Table 9 Global DNA Microarray Market Outlook, By Hybridization (2023-2034) ($MN)
  • Table 10 Global DNA Microarray Market Outlook, By Other Technologies (2023-2034) ($MN)
  • Table 11 Global DNA Microarray Market Outlook, By Application (2023-2034) ($MN)
  • Table 12 Global DNA Microarray Market Outlook, By Gene Expression Analysis (2023-2034) ($MN)
  • Table 13 Global DNA Microarray Market Outlook, By Cancer Research (2023-2034) ($MN)
  • Table 14 Global DNA Microarray Market Outlook, By Genotyping (2023-2034) ($MN)
  • Table 15 Global DNA Microarray Market Outlook, By Genetics (2023-2034) ($MN)
  • Table 16 Global DNA Microarray Market Outlook, By Drug Discovery (2023-2034) ($MN)
  • Table 17 Global DNA Microarray Market Outlook, By Forensic Science (2023-2034) ($MN)
  • Table 18 Global DNA Microarray Market Outlook, By Neuroscience (2023-2034) ($MN)
  • Table 19 Global DNA Microarray Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 20 Global DNA Microarray Market Outlook, By End User (2023-2034) ($MN)
  • Table 21 Global DNA Microarray Market Outlook, By Contract Research Organizations (CROs) (2023-2034) ($MN)
  • Table 22 Global DNA Microarray Market Outlook, By Biotechnology Companies (2023-2034) ($MN)
  • Table 23 Global DNA Microarray Market Outlook, By Hospitals and Clinics (2023-2034) ($MN)
  • Table 24 Global DNA Microarray Market Outlook, By Academic and Research Institutes (2023-2034) ($MN)
  • Table 25 Global DNA Microarray Market Outlook, By Diagnostic Centers (2023-2034) ($MN)
  • Table 26 Global DNA Microarray Market Outlook, By Other End Users (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.